Concerns Over Using ARV Therapy As Prevention Strategy

PSI’s “Healthy Lives” blog reviews a recent Science magazine article written by James Shelton of USAID’s Bureau of Global Health in which he raises concerns about the use of antiretroviral drugs (ARVs) as a prevention strategy. The blog notes he especially expresses concerns over drug adherence and resistance. “Dr. Shelton does not entirely dismiss the usefulness of ARVs, but seeks to look a bit more critically at how effective they are as a prevention tool,” the blog states, noting that Shelton’s article concludes, “ARVs are no ‘magic bullet.’ But ARVs’ best potential is to contribute to the existing combination arsenal, which, well applied, can have a major impact in stemming the global HIV pandemic” (1/6).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.